Shenglan Yang

1.3k total citations
37 papers, 1.1k citations indexed

About

Shenglan Yang is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shenglan Yang has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shenglan Yang's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Shenglan Yang is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Shenglan Yang collaborates with scholars based in China, United States and South Africa. Shenglan Yang's co-authors include Chen Chen, Dao Wen Wang, Yan Wang, Fuqiong Chen, Wei Gong, Feng Wang, Quanlu Duan, Guangwen Long, Yingying Luo and Haijun Qi and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Shenglan Yang

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenglan Yang China 15 612 517 148 102 81 37 1.1k
Alexandre Mezentsev Russia 17 543 0.9× 186 0.4× 139 0.9× 70 0.7× 54 0.7× 43 1.0k
Laura M. López‐Sánchez Spain 19 489 0.8× 188 0.4× 127 0.9× 30 0.3× 197 2.4× 34 1.1k
Clare Murray United Kingdom 17 704 1.2× 503 1.0× 100 0.7× 72 0.7× 56 0.7× 31 1.3k
Wolfgang A. Schmalix Germany 20 464 0.8× 275 0.5× 123 0.8× 20 0.2× 44 0.5× 35 1.0k
Émilie Thivat France 19 401 0.7× 286 0.6× 60 0.4× 41 0.4× 46 0.6× 60 1.2k
Ingalill Avis United States 19 911 1.5× 323 0.6× 130 0.9× 28 0.3× 162 2.0× 42 1.8k
Shanshan Luo China 16 401 0.7× 107 0.2× 214 1.4× 75 0.7× 35 0.4× 33 752
Xu Zhao China 17 602 1.0× 388 0.8× 35 0.2× 30 0.3× 132 1.6× 65 1.1k
Kenji Kuwabara Japan 14 315 0.5× 167 0.3× 52 0.4× 133 1.3× 52 0.6× 23 938
Zhiqiang Cheng China 16 509 0.8× 270 0.5× 46 0.3× 28 0.3× 63 0.8× 50 1.0k

Countries citing papers authored by Shenglan Yang

Since Specialization
Citations

This map shows the geographic impact of Shenglan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Yang more than expected).

Fields of papers citing papers by Shenglan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Yang. The network helps show where Shenglan Yang may publish in the future.

Co-authorship network of co-authors of Shenglan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglan Yang. A scholar is included among the top collaborators of Shenglan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglan Yang. Shenglan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Shenglan, et al.. (2025). Greenhouse gas emissions in China’s national Parks: A 2020 National-Scale analysis and Implications for management. Ecological Indicators. 170. 113089–113089. 2 indexed citations
2.
Yang, Shenglan, et al.. (2025). Exposure to Per‐ and Polyfluoroalkyl Substances and the Risk of Prostate and Ovarian Cancer: An Epidemiologic Meta‐Analysis. American Journal of Industrial Medicine. 68(5). 399–412.
3.
4.
Yang, Shenglan, et al.. (2025). Identifying potential action points for reducing kinesiophobia among atrial fibrillation patients: a network and DAG analysis. Quality of Life Research. 34(5). 1253–1264. 3 indexed citations
5.
Li, Xiaorong, et al.. (2025). Cardiomyocyte-specific deletion of STING improves cardiac function, glucose homeostasis, and wound healing in diabetic mice. Life Sciences. 366-367. 123470–123470. 1 indexed citations
6.
Yang, Shenglan, et al.. (2024). Physical activity modifies the association between atherogenic index of plasma and prediabetes and diabetes: A cross‐sectional analysis. Journal of Diabetes. 16(10). e70006–e70006. 2 indexed citations
8.
Wang, Shuhan, Fangyuan Zhou, Zhang Mengqi, et al.. (2024). Dachengqi decoction ameliorated liver injury in liver fibrosis mice by maintaining gut vascular barrier integrity. Phytomedicine. 136. 156272–156272. 1 indexed citations
10.
Qin, Yuhong, Yani Shi, Qi Yu, et al.. (2023). Vitamin B12 alleviates myocardial ischemia/reperfusion injury via the SIRT3/AMPK signaling pathway. Biomedicine & Pharmacotherapy. 163. 114761–114761. 14 indexed citations
11.
Wang, Fangyi, et al.. (2023). Over 1/4 of China's terrestrial area significantly contributed both to biodiversity conservation and carbon neutrality, requiring protection. The Science of The Total Environment. 912. 169070–169070. 6 indexed citations
12.
You, Yuehua, Fei‐Fei Shang, Xiaowen Wang, et al.. (2023). iNOS aggravates pressure overload-induced cardiac dysfunction via activation of the cytosolic-mtDNA-mediated cGAS-STING pathway. Theranostics. 13(12). 4229–4246. 26 indexed citations
13.
Luo, Minghao, Yu Hu, Dingyi Lv, et al.. (2022). Recurrent Hypoglycemia Impaired Vascular Function in Advanced T2DM Rats by Inducing Pyroptosis. Oxidative Medicine and Cellular Longevity. 2022(1). 7812407–7812407. 11 indexed citations
14.
Chen, Chen, Shenglan Yang, Huaping Li, et al.. (2017). Mir30c Is Involved in Diabetic Cardiomyopathy through Regulation of Cardiac Autophagy via BECN1. Molecular Therapy — Nucleic Acids. 7. 127–139. 57 indexed citations
16.
Zhu, Rui, et al.. (2015). Effect of Quyu Chencuo Formula (去菀陈莝方) on Renal Fibrosis in Obstructive Nephropathy Rats. Chinese Journal of Integrative Medicine. 25(3). 190–196.
17.
Zhao, Gang, Ling Tu, Xuguang Li, et al.. (2012). Delivery of AAV2-CYP2J2 Protects Remnant Kidney in the 5/6-Nephrectomized Rat via Inhibition of Apoptosis and Fibrosis. Human Gene Therapy. 23(7). 688–699. 57 indexed citations
18.
Long, Guangwen, Feng Wang, Quanlu Duan, et al.. (2012). Circulating miR-30a, miR-195 and let-7b Associated with Acute Myocardial Infarction. PLoS ONE. 7(12). e50926–e50926. 117 indexed citations
19.
Chen, Fuqiong, Chen Chen, Shenglan Yang, et al.. (2012). Let-7b Inhibits Human Cancer Phenotype by Targeting Cytochrome P450 Epoxygenase 2J2. PLoS ONE. 7(6). e39197–e39197. 51 indexed citations
20.
Chen, Chen, Xin Wei, Xiaoquan Rao, et al.. (2010). Cytochrome P450 2J2 Is Highly Expressed in Hematologic Malignant Diseases and Promotes Tumor Cell Growth. Journal of Pharmacology and Experimental Therapeutics. 336(2). 344–355. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026